• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-CTLA4 antibody-induced lupus nephritis.

作者信息

Fadel Fouad, El Karoui Khalil, Knebelmann Bertrand

出版信息

N Engl J Med. 2009 Jul 9;361(2):211-2. doi: 10.1056/NEJMc0904283.

DOI:10.1056/NEJMc0904283
PMID:19587352
Abstract
摘要

相似文献

1
Anti-CTLA4 antibody-induced lupus nephritis.抗CTLA4抗体诱导的狼疮性肾炎。
N Engl J Med. 2009 Jul 9;361(2):211-2. doi: 10.1056/NEJMc0904283.
2
Anti-CTLA-4 antibody-induced Guillain-Barré syndrome in a melanoma patient.一名黑色素瘤患者中抗CTLA-4抗体诱发的吉兰-巴雷综合征
Ann Oncol. 2011 Apr;22(4):991-993. doi: 10.1093/annonc/mdr028. Epub 2011 Feb 28.
3
Melanoma drug wins US approval.黑色素瘤药物获美国批准。
Nature. 2011 Mar 31;471(7340):561. doi: 10.1038/471561a.
4
Clinical development of the anti-CTLA-4 antibody tremelimumab.抗 CTLA-4 抗体 tremelimumab 的临床开发。
Semin Oncol. 2010 Oct;37(5):450-4. doi: 10.1053/j.seminoncol.2010.09.010.
5
CTLA4-induced splenomegaly and a review of the literature pertaining to autoimmune complications of therapy.细胞毒性T淋巴细胞相关抗原4（CTLA4）诱导的脾肿大及关于治疗自身免疫性并发症的文献综述
J Drugs Dermatol. 2010 Nov;9(11):1432-6.
6
The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications.抗 CTLA-4 抗体在各种临床适应证中的新兴毒性特征。
Semin Oncol. 2010 Oct;37(5):499-507. doi: 10.1053/j.seminoncol.2010.09.007.
7
Novel therapies targeting the immune system: CTLA4 blockade with tremelimumab (CP-675,206), a fully human monoclonal antibody.针对免疫系统的新型疗法：用曲美木单抗（CP-675,206）进行CTLA4阻断，曲美木单抗是一种全人源单克隆抗体。
Expert Opin Investig Drugs. 2008 Mar;17(3):371-85. doi: 10.1517/13543784.17.3.371.
8
[Treatment of metastatic melanoma with CTLA4 antibodies].[用细胞毒性T淋巴细胞相关抗原4抗体治疗转移性黑色素瘤]
Hautarzt. 2010 Sep;61(9):808-10. doi: 10.1007/s00105-010-2033-5.
9
Autoimmune inflammatory myopathy after treatment with ipilimumab.使用伊匹单抗治疗后出现的自身免疫性炎性肌病。
Can J Neurol Sci. 2009 Jul;36(4):518-20. doi: 10.1017/s0317167100007939.
10
Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma.CTLA-4 抗体治疗转移性黑色素瘤的治疗和副作用管理。
J Dtsch Dermatol Ges. 2011 Apr;9(4):277-86. doi: 10.1111/j.1610-0387.2010.07568.x. Epub 2010 Nov 17.

引用本文的文献

1
Acute kidney injury: pathogenesis and therapeutic interventions.急性肾损伤：发病机制与治疗干预
Mol Biomed. 2025 Sep 5;6(1):61. doi: 10.1186/s43556-025-00293-4.
2
pH-dependent dissociation from CTLA-4 in early endosomes improves both safety and antitumor activity of anti-CTLA-4 antibodies.早期内体中pH依赖的从细胞毒性T淋巴细胞相关抗原4（CTLA-4）的解离改善了抗CTLA-4抗体的安全性和抗肿瘤活性。
Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2422731122. doi: 10.1073/pnas.2422731122. Epub 2025 Feb 18.
3
Refractory hypokalemia and metabolic acidosis induced by undifferentiated connective tissue disease secondary to immune checkpoint inhibitors: a case report and literature review.
免疫检查点抑制剂继发的未分化结缔组织病所致难治性低钾血症和代谢性酸中毒：一例报告及文献复习
Front Oncol. 2024 Nov 26;14:1442605. doi: 10.3389/fonc.2024.1442605. eCollection 2024.
4
Immunotherapies and Renal Injury.免疫疗法与肾损伤
Curr Opin Toxicol. 2022 Sep;31. doi: 10.1016/j.cotox.2022.100362. Epub 2022 Jun 27.
5
Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report.替雷利珠单抗致晚期食管鳞状细胞癌患者双器官功能障碍：一例报告
Front Oncol. 2024 Mar 14;14:1347896. doi: 10.3389/fonc.2024.1347896. eCollection 2024.
6
Immune checkpoint inhibitors and acute kidney injury.免疫检查点抑制剂与急性肾损伤。
Front Immunol. 2024 Feb 23;15:1353339. doi: 10.3389/fimmu.2024.1353339. eCollection 2024.
7
Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy.癌症免疫治疗中免疫检查点抑制剂的风湿性不良事件。
Expert Rev Clin Immunol. 2024 Aug;20(8):873-893. doi: 10.1080/1744666X.2024.2323966. Epub 2024 Mar 19.
8
Immune Checkpoint Inhibitors and Lupus Erythematosus.免疫检查点抑制剂与红斑狼疮
Pharmaceuticals (Basel). 2024 Feb 15;17(2):252. doi: 10.3390/ph17020252.
9
Nephrotic syndrome with acute kidney injury due to combination therapy of immune checkpoint inhibitors: a case report and review of the literature.免疫检查点抑制剂联合治疗导致的肾病综合征伴急性肾损伤：病例报告及文献复习。
BMC Nephrol. 2024 Feb 9;25(1):51. doi: 10.1186/s12882-024-03494-1.
10
Research Progress of PD 1/PD L1 Inhibitors in the Treatment of Urological Tumors.PD-1/PD-L1 抑制剂在治疗泌尿系统肿瘤中的研究进展。
Curr Cancer Drug Targets. 2024;24(11):1104-1115. doi: 10.2174/0115680096278251240108152600.